glp-1 patent Ozempic, Wegovy and Rybelsus: The patents behind Novo Nordisk's weight-loss drugs Competing in the Post-Patent GLP-1

"I was very comfortable with peptides as a potential medicine." To make the GLP-1 hormone "long-acting" her team found a way to attach a fatty acid to the molecule

personal misuse

In native form, IGF-1 is tightly regulated by these proteins, limiting free circulating activity

The R -gene mediated, hypersensitive-type resistance (HR, incompatible interaction) is based on a specific interaction, either directly or indirectly, of a bacterial effector gene product with the R gene of the host plant

The Kraus 2014 Nature Paper: Why Adipose Research Specifically The 2014 Nature paper by Kraus and colleagues (titled "Nicotinamide N-methyltransferase knockdown protects against diet-induced obesity") established the adipose-NNMT connection that anchors all subsequent NNMT-inhibition research in fat biology